- Home
- TRT vs INKT Comparison
TRT vs INKT Comparison
Compare TRT & INKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRT
- INKT
- Stock Information
- Founded
- TRT 1958
- INKT 2017
- Country
- TRT United States
- INKT United States
- Employees
- TRT N/A
- INKT N/A
- Industry
- TRT Industrial Machinery/Components
- INKT Medicinal Chemicals and Botanical Products
- Sector
- TRT Technology
- INKT Health Care
- Exchange
- TRT Nasdaq
- INKT Nasdaq
- Market Cap
- TRT 27.6M
- INKT 28.5M
- IPO Year
- TRT N/A
- INKT 2021
- Fundamental
- Price
- TRT $6.20
- INKT $0.46
- Analyst Decision
- TRT
- INKT Strong Buy
- Analyst Count
- TRT 0
- INKT 2
- Target Price
- TRT N/A
- INKT $6.50
- AVG Volume (30 Days)
- TRT 8.1K
- INKT 43.7K
- Earning Date
- TRT 02-10-2025
- INKT 11-14-2024
- Dividend Yield
- TRT N/A
- INKT N/A
- EPS Growth
- TRT N/A
- INKT N/A
- EPS
- TRT 0.24
- INKT N/A
- Revenue
- TRT $42,312,000.00
- INKT N/A
- Revenue This Year
- TRT N/A
- INKT N/A
- Revenue Next Year
- TRT N/A
- INKT N/A
- P/E Ratio
- TRT $27.14
- INKT N/A
- Revenue Growth
- TRT N/A
- INKT N/A
- 52 Week Low
- TRT $4.64
- INKT $0.46
- 52 Week High
- TRT $7.88
- INKT $1.90
- Technical
- Relative Strength Index (RSI)
- TRT 38.09
- INKT 15.27
- Support Level
- TRT $6.53
- INKT $0.64
- Resistance Level
- TRT $6.88
- INKT $0.67
- Average True Range (ATR)
- TRT 0.20
- INKT 0.06
- MACD
- TRT -0.07
- INKT -0.02
- Stochastic Oscillator
- TRT 5.43
- INKT 0.00
About TRT Trio-Tech International
Trio-Tech International is a provider of third-party semiconductor testing and burn-in services through its laboratories in Southeast Asia. The company operates in four segments namely Manufacturing, Testing services, Distribution, and Real Estate. Its Manufacturing segment manufactures both front-end and back-end semiconductor test equipment and related peripherals. The Testing Services segment renders services to the manufacturer and purchaser of semiconductors and other entities. Its Distribution segment is involved in the distribution of its products. The company's Real Estate segment consists of investment in real estate. Its geographical area of operations includes the United States, Singapore, Malaysia, Thailand, and China. It derives maximum revenue from Testing services Segment.
About INKT MiNK Therapeutics Inc.
MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing allogeneic invariant natural killer T-cell therapies to treat cancer and other life-threatening illnesses.